# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-017899
Filing Date
2025-02-11
Accepted
2025-02-11 16:10:29
Documents
107
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | crsp-20241231.htm iXBRL | 10-K | 4119978
2 | EX-4.1 | crsp-ex4_1.htm | EX-4.1 | 27115
3 | EX-10.35 | crsp-ex10_35.htm | EX-10.35 | 113629
4 | EX-19.1 | crsp-ex19_1.htm | EX-19.1 | 126927
5 | EX-21.1 | crsp-ex21_1.htm | EX-21.1 | 6922
6 | EX-23.1 | crsp-ex23_1.htm | EX-23.1 | 7431
7 | EX-31.1 | crsp-ex31_1.htm | EX-31.1 | 13888
8 | EX-31.2 | crsp-ex31_2.htm | EX-31.2 | 13862
9 | EX-32.1 | crsp-ex32_1.htm | EX-32.1 | 12225
10 | GRAPHIC | img169374432_0.jpg | GRAPHIC | 272537
11 | GRAPHIC | img169374432_1.jpg | GRAPHIC | 444376
12 | GRAPHIC | img169374432_2.jpg | GRAPHIC | 150330
13 | GRAPHIC | img169374432_3.jpg | GRAPHIC | 509889
14 | GRAPHIC | img169374432_4.jpg | GRAPHIC | 472242
15 | GRAPHIC | img169374432_5.jpg | GRAPHIC | 336661
16 | GRAPHIC | img169374432_6.jpg | GRAPHIC | 213824
17 | GRAPHIC | img169374432_7.jpg | GRAPHIC | 209346
18 | GRAPHIC | img169374432_8.jpg | GRAPHIC | 251131
19 | GRAPHIC | img169374432_9.jpg | GRAPHIC | 201580
20 | GRAPHIC | img169374432_10.jpg | GRAPHIC | 126960
21 | GRAPHIC | img169374432_11.jpg | GRAPHIC | 274665
22 | GRAPHIC | img169374432_12.jpg | GRAPHIC | 345951
23 | GRAPHIC | img169374432_13.jpg | GRAPHIC | 1095252
| Complete submission text file | 0000950170-25-017899.txt |  | 26836831

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
24 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | crsp-20241231.xsd | EX-101.SCH | 1602557
110 | EXTRACTED XBRL INSTANCE DOCUMENT | crsp-20241231_htm.xml | XML | 2985698

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37923 | Film No.: 25609891
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)